30 Oct 2017
CULPRIT-SHOCK, EXCEL and DKCRUSH-V: TCT 2017 Late Breaking Trial Results
30 Oct 2017
Two potentially impactful clinical trials were in the limelight during day 2 of TCT 2017, as well as the quality of life analysis of a trial comparing revascularization strategies for left main disease. Let’s take a look at the results and see what their potential could be for daily practice.
PCR @ TCT 2017
We will be covering a selection of major Late-breaking Clinical Trials in Interventional Cardiology to be released at the 2017 Transcatheter Cardiovascular Therapeutics Scientific Sessions. Get the European Perspective!
Efficacy and safety of Ticagrelor over time in patients with prior MI in PEGASUS-TIMI 54
19 Oct 2017
Spontaneous haematoma, dissection: a broken heart bleeds tears
Consult this session on spontaneous haematoma, dissection: a broken heart bleeds tears from EuroPCR 2017 if you want to learn more about the following clinical cases:
- Let the nature heal: avoiding coronary implant in the young
- Spontaneous coronary artery dissection needs a hawk's eye all the times
- Multivessel primary PCI in STEMI complicated with cardiogenic shock in young woman two weeks post partum
- Spontaneous coronary artery dissection. Stent or not to stent? Two different approaches
- Spontaneous dissection of the left main at one week postpartum managed by PCI
- Extensive coronary dissection in STEMI: multimodality intravascular imaging guided-PCI in a large, tortuous right coronary artery
- Spontaneous dissection
2017 ESC Focused update on Dual Antiplatelet Therapy (DAPT)
04 Sep 2017
As dual antiplatelet therapy (DAPT) seems to have been interventionalists’ close companion since the pioneering studies showing its benefits over oral anticoagulants (OAC) some 20 years ago, the myriad of ensuing studies has led to expanding indications, but has also uncovered the inherent risks of DAPT. In the 2017 Focused Update, the hitherto accumulated evidence is eloquently summarized into a set of recommendations that provide guidance on some of the important questions of an interventional cardiologist's everyday practice: which of the currently available P2Y12 inhibitors should be selected, what is the optimal duration of DAPT and how to manage bleeding complications.
Oxygen Therapy in Suspected Acute Myocardial Infarction
30 Aug 2017
New ESC Guidelines on Acute Myocardial Infarction in patients presenting with ST-segment elevation (STEMI)
30 Aug 2017
Within the four guidelines released at the ESC Congress 2017, the STEMI guidelines may probably represent one of the most interesting for our community. Many of the changes in recommendations were already expected by many of us, whereas others are important to see and to digest.
VALIDATE-SWEDEHEART, TROPICAL-ACS and RE-DUAL PCI: Antithrombotic Therapy takes the stage
In the accompanying editorial of COMPASS, presented at the ESC Congress 2017 in Barcelona, Eugene Braunwald vividly referred to the field of “Thrombocardiology”. Indeed, the topic of antithrombotic pharmacotherapy is now broader than ever, with plenty of drugs, indications, strategies and clinical data. Three new trials (with simultaneous publications in the New England Journal of Medicine and in The Lancet) clarify doubts, inform clinical practice and open new questions.
Ticagrelor or clopidogrel in DAPT for acute coronary syndromes: A call for a stepwise approach?
COOL AMI EU pilot trial: a multicentre, prospective, randomised controlled trial to assess cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction
10 Aug 2017